Literature DB >> 3479615

Sympathoadrenal and other responses to hypoglycaemia in the young foal.

M Silver1, A L Fowden, J Knox, J C Ousey, R Franco, P D Rossdale.   

Abstract

The effects of insulin-induced hypoglycaemia on plasma catecholamines, cortisol and metabolites have been examined in newborn and 7-14-day-old foals. The fall in plasma glucose elicited by the highest dose of insulin (1.0 i.u./kg) given to the neonates was slower in onset and less severe in effect than 0.5 i.u./kg in the older foals. There was a significant inverse correlation between the concentrations of glucose and adrenaline (but not noradrenaline) in plasma once the glucose level had fallen below 2 mmol/l; the adrenergic response to hypoglycaemia was greater in the 7-14-day-old foals than in the neonates. No significant changes in glucose or catecholamines were seen after fasting alone. The adrenocortical response to hypoglycaemia was poor after birth, but significant changes occurred in the older foals with a 3-fold increase in plasma cortisol at 60 min after 0.5 i.u. insulin/kg. There were significant increases in plasma FFA after hypoglycaemia in both groups of animals, but the rise was less pronounced in the neonates. A significant positive correlation was found between plasma adrenaline and FFA values. Hypoglycaemia also resulted in a significant rise in plasma lactate and a slow fall in alpha-amino nitrogen. These findings show that hypoglycaemia in the foal is followed by stimulation of the adrenal medullary component of the sympathetic system and by activation of the adrenal cortex with a number of consequent metabolic changes. The hypoglycaemic effects of insulin were more intense and the response more rapid in the older foals than in the neonates, which exhibited some degree of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3479615

Source DB:  PubMed          Journal:  J Reprod Fertil Suppl        ISSN: 0449-3087


  9 in total

1.  Neonatal hypoglycaemia in Nepal 1. Prevalence and risk factors.

Authors:  D K Pal; D S Manandhar; S Rajbhandari; J M Land; N Patel; A M de L Costello
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-01       Impact factor: 5.747

2.  Developmental regulation of glucogenesis in the sheep fetus during late gestation.

Authors:  A L Fowden; L Mundy; M Silver
Journal:  J Physiol       Date:  1998-05-01       Impact factor: 5.182

3.  Hormonal and metabolic response to hypoglycaemia in small for gestational age infants.

Authors:  J M Hawdon; A Weddell; A Aynsley-Green; M P Ward Platt
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

4.  Effects of low-dose hydrocortisone therapy on immune function in neonatal horses.

Authors:  Kelsey A Hart; Michelle H Barton; Michel L Vandenplas; David J Hurley
Journal:  Pediatr Res       Date:  2011-07       Impact factor: 3.756

Review 5.  Adrenocortical insufficiency in horses and foals.

Authors:  Kelsey A Hart; Michelle H Barton
Journal:  Vet Clin North Am Equine Pract       Date:  2011-04       Impact factor: 1.792

6.  Ovine feto-placental metabolism.

Authors:  J W Ward; F B P Wooding; A L Fowden
Journal:  J Physiol       Date:  2003-10-31       Impact factor: 5.182

7.  Cardiopulmonary effects of hypercapnia during controlled intermittent positive pressure ventilation in the horse.

Authors:  A K Khanna; W N McDonell; D H Dyson; P M Taylor
Journal:  Can J Vet Res       Date:  1995-07       Impact factor: 1.310

8.  Postnatal cardiovascular function after manipulation of fetal growth by embryo transfer in the horse.

Authors:  Dino A Giussani; Alison J Forhead; David S Gardner; Andrew J W Fletcher; W R Allen; Abigail L Fowden
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

9.  Comparison of insulin sensitivity between healthy neonatal foals and horses using minimal model analysis.

Authors:  Hannah M Kinsella; Laura D Hostnik; Hailey A Snyder; Sarah E Mazur; Ahmed M Kamr; Teresa A Burns; John C Mossbarger; Ramiro E Toribio
Journal:  PLoS One       Date:  2022-01-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.